NVCT Competitors & Alternatives
Compare Nuvectis Pharma Inc with similar stocks in the same industry
Biotechnology
NVCT
Main Stock$18.29
Tradestie Score
51
Market Cap
$154.27M
Analyst Upside
+73.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$19.50
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$5.69
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
ANL
ANL
|
$9.20
|
$595.04M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.66
|
$552.46M | - | 59 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.97
|
$540.97M | - | 61 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.06
|
$529.35M | 6.6 | 54 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$99.79
|
$522.78M | - | 59 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.12
|
$512.39M | - | 51 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$41.17
|
$505.12M | 2.2 | 62 | Compare |
More NVCT Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry